Evidence map›Paper›PMID 34504269›Full record

ArticleScientific reports2021

Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder.

Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Georgi Tosev *Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany. dr.tosev@yahoo.com.
Wasilijiang Wahafu *Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Philipp ReimoldDepartment of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Ivan DamgovDivision of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.
Constantin SchwabDepartment of General Pathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Cem AksoyDepartment of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Adam KaczorowskiMolecular Urooncology, University Hospital Heidelberg, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
Albrecht StenzingerDepartment of General Pathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Joanne Nyarangi-DixDepartment of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Markus HohenfellnerDepartment of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Stefan DuensingDepartment of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.
Heidelberg University · DEUniversity Hospital Heidelberg · DEChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34504269
PMCPMC8429570
OpenAlexW3197780585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.